| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Feb 28, 2024 | Sale | $155.30 | 574 | 89,145 | 19,805 | Feb 29, 2024, 04:18 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Feb 16, 2024 | Sale | $148.06 | 1,007 | 149,099 | 18,782 | Feb 20, 2024, 04:08 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Aug 04, 2023 | Sale | $185.85 | 3,460 | 643,037 | 18,675 | Aug 07, 2023, 06:05 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Apr 27, 2023 | Sale | $194.59 | 977 | 190,113 | 12,602 | Apr 28, 2023, 05:55 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Aug 04, 2022 | Option Exercise | $191.69 | 5,054 | 968,824 | 9,887 | Aug 05, 2022, 04:14 PM |
Menu